157 related articles for article (PubMed ID: 36462101)
1. miR-375 Combined with SHOX2 Methylation has Higher Diagnostic Efficacy for Non-Small-Cell Lung Cancer.
Zeng S; Lin C; Huang Y
Mol Biotechnol; 2023 Jul; 65(7):1187-1197. PubMed ID: 36462101
[TBL] [Abstract][Full Text] [Related]
2. A Novel Diagnosis Method Based on Methylation Analysis of SHOX2 and Serum Biomarker for Early Stage Lung Cancer.
Huang W; Huang H; Zhang S; Wang X; Ouyang J; Lin Z; Chen P
Cancer Control; 2020; 27(1):1073274820969703. PubMed ID: 33167712
[TBL] [Abstract][Full Text] [Related]
3. Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease.
Weiss G; Schlegel A; Kottwitz D; König T; Tetzner R
J Thorac Oncol; 2017 Jan; 12(1):77-84. PubMed ID: 27544059
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation of the homeobox genes PITX2 and SHOX2 predicts outcome in non-small-cell lung cancer patients.
Dietrich D; Hasinger O; Liebenberg V; Field JK; Kristiansen G; Soltermann A
Diagn Mol Pathol; 2012 Jun; 21(2):93-104. PubMed ID: 22555092
[TBL] [Abstract][Full Text] [Related]
5. Combined Methylation of
Zhong Q; Wang Y; Liang C; Wei F; She B
Discov Med; 2023 Oct; 35(178):845-852. PubMed ID: 37811622
[TBL] [Abstract][Full Text] [Related]
6. [DNA methylation detection of SHOX2 and PTGER4 in plasma contributes to differential diagnosis of pulmonary nodule patients].
Chu X; Zhao W; Wang B
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Apr; 35(4):357-361. PubMed ID: 31167696
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic Efficacy of SHOX2 Gene Hypermethylation for Lung Cancer: A Meta-Analysis].
Liu Q; Wang S; Pei G; Yang Y; Huang Y
Zhongguo Fei Ai Za Zhi; 2021 Jul; 24(7):490-496. PubMed ID: 34275516
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of SHOX2 promoter methylation as biomarker for lung cancer identification: A meta-analysis update.
Zhou X; Lu X; Wu H; Liu J; Huang H
Thorac Cancer; 2021 Dec; 12(24):3327-3332. PubMed ID: 34741433
[TBL] [Abstract][Full Text] [Related]
9. Correlation of SHOX2 gene amplification and DNA methylation in lung cancer tumors.
Schneider KU; Dietrich D; Fleischhacker M; Leschber G; Merk J; Schäper F; Stapert HR; Vossenaar ER; Weickmann S; Liebenberg V; Kneip C; Seegebarth A; Erdogan F; Rappold G; Schmidt B
BMC Cancer; 2011 Mar; 11():102. PubMed ID: 21426551
[TBL] [Abstract][Full Text] [Related]
10. Analysis of SHOX2 methylation as an aid to cytology in lung cancer diagnosis.
Ilse P; Biesterfeld S; Pomjanski N; Wrobel C; Schramm M
Cancer Genomics Proteomics; 2014; 11(5):251-8. PubMed ID: 25331797
[TBL] [Abstract][Full Text] [Related]
11. Association of the SHOX2 and RASSF1A methylation levels with the pathological evolution of early-stage lung adenocarcinoma.
Zhao J; Lu Y; Ren X; Bian T; Feng J; Sun H; Liu L; She B; Liu Y; Ke H
BMC Cancer; 2024 Jun; 24(1):687. PubMed ID: 38840077
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of RASSF1A and SHOX2 methylation combined with EGFR mutations for differentiation between small pulmonary nodules.
Ji XY; Li H; Chen HH; Lin J
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8557-8571. PubMed ID: 37097393
[TBL] [Abstract][Full Text] [Related]
13. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma.
Kneip C; Schmidt B; Seegebarth A; Weickmann S; Fleischhacker M; Liebenberg V; Field JK; Dietrich D
J Thorac Oncol; 2011 Oct; 6(10):1632-8. PubMed ID: 21694641
[TBL] [Abstract][Full Text] [Related]
14. Detection of SHOX2 DNA methylation by methylation-specific PCR in non-small cell lung cancer.
Feng H; Shao W; Du L; Qing X; Zhang Z; Liang C; Liu D
Transl Cancer Res; 2020 Oct; 9(10):6070-6077. PubMed ID: 35117218
[TBL] [Abstract][Full Text] [Related]
15. The value of SHOX2 methylation test in peripheral blood samples used for the differential diagnosis of lung cancer and other lung disorders.
Konecny M; Markus J; Waczulikova I; Dolesova L; Kozlova R; Repiska V; Novosadova H; Majer I
Neoplasma; 2016; 63(2):246-53. PubMed ID: 26774146
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of exfoliated tumor cells combined with DNA methylation in bronchoalveolar lavage fluid for lung cancer.
Lu H; Lin D
Medicine (Baltimore); 2023 Sep; 102(36):e34955. PubMed ID: 37682182
[TBL] [Abstract][Full Text] [Related]
17. Identification of serum MiRNAs as candidate biomarkers for non-small cell lung cancer diagnosis.
Zhang X; Tan J; Chen Y; Ma S; Bai W; Peng Y; Shi G
BMC Pulm Med; 2022 Dec; 22(1):479. PubMed ID: 36522766
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation of microRNA-coding genes in non-small-cell lung cancer patients.
Heller G; Altenberger C; Steiner I; Topakian T; Ziegler B; Tomasich E; Lang G; End-Pfützenreuter A; Zehetmayer S; Döme B; Arns BM; Klepetko W; Zielinski CC; Zöchbauer-Müller S
J Pathol; 2018 Aug; 245(4):387-398. PubMed ID: 29570800
[TBL] [Abstract][Full Text] [Related]
19. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer.
Shi GL; Chen Y; Sun Y; Yin YJ; Song CX
Clin Lab; 2017 Jan; 63(1):133-140. PubMed ID: 28164492
[TBL] [Abstract][Full Text] [Related]
20. [Clinical value of tumor-associated autoantibodies in diagnosis of early non-small cell lung cancer].
Ren Z; Ding HM; Qian X; Pan SY
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Dec; 55(12):1426-1434. PubMed ID: 34963239
[No Abstract] [Full Text] [Related]
[Next] [New Search]